Pfizer Expands License for Ingenuity s Pathway-Analysis Software | GenomeWeb

NEW YORK, March 1 (GenomeWeb News) - Pfizer has expanded its license for Ingenuity Systems' Pathway Analysis software, Mountain View, Calif.-based Ingenuity said today.

Under the expanded agreement, more Pfizer researchers will have access to Ingenuity's software.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.